BioMarin Pharmaceutical | BMRN - Ebitda



金融业
股票价格
USD 56.03
资产
USD 11.57B
现金及等价物
USD 736.01M
销售成本
USD 304.87M
流动资产
USD 3.92B
流动负债
USD 1.6B
债务
USD 4.2B
EBIT
USD 205.6M
EBITDA
USD 222.32M
员工
3.04K
EPS每股收益
USD 0.23
股本和储备
USD 6.26B
销售毛利
USD 719.77M
债务利息支出
USD 55.63M
利息收入
USD 10.48M
贷款资金
USD 3.51B
市值
USD 10.7B
净收入
USD -122.83M
营业费用
USD 819.04M
营业利润
USD 205.6M
普通股股本
USD 193.54M
PE价格收益
53.62
税前利润
USD 61.38M
销售收入
USD 1.03B
销售和管理费用
USD 333.64M
股票
USD 1.8B
贸易债权人
USD 946.11M
应收帐款人
USD 1.08B


Ebitda 更改 日
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Bayer EUR 1.62B 529M 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Insmed USD -80.97M 93.7M 2026-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Moderna USD -687M 571M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 6.66B 4.99B 2026-09
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
United Therapeutics USD 334.2M 20.8M 2026-09
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06